Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in ZYME — Zymeworks Inc.

CIK 1000275 TORONTO, A6
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,471,104
+$285,210 QoQ
Shares Held
56,278
+18.8% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 202 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. ZYME ranks #57 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in ZYME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,471,104 56,278
2026-03-31 $1,185,894 47,360
2025-12-31 $1,449,595 55,055
2025-09-30 $989,357 57,925
2025-06-30 $915,934 72,983
2025-03-31 $676,140 56,771
2024-12-31 $891,954 60,926
2024-09-30 $776,566 61,878
2024-06-30 $558,492 65,628
2024-03-31 $726,026 69,014
2023-12-31 $885,090 85,187
2023-09-30 $518,318 81,754
2023-06-30 $1,041,420 120,535
2023-03-31 $1,549,265 171,379
2022-12-31 $1,323,756 168,417